Weekly docetaxel/carboplatin as primary systemic therapy for HER2-negative locally advanced breast cancer

J Hurley, I Reis, O Silva, C Gomez, P Velez, C Welsh, J Powell, P Doliny; Fernando I de Zarraga; Fernando I deZarraga

Weekly docetaxel/carboplatin as primary systemic therapy for HER2-negative locally advanced breast cancer

J Hurley, I Reis, O Silva, C Gomez, P Velez, C Welsh, J Powell, P Doliny, Fernando I de Zarraga, Fernando I deZarraga

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Clinical Breast Cancer
Volume	5
State	Published - 2005

Disciplines

Medicine and Health Sciences

Cite this

@article{e7fe4f8d5d224276953956ee377dcad7,

title = "Weekly docetaxel/carboplatin as primary systemic therapy for HER2-negative locally advanced breast cancer",

author = "\{P Doliny\}, \{J Hurley, I Reis, O Silva, C Gomez, P Velez, C Welsh, J Powell,\} and \{de Zarraga\}, \{Fernando I\} and deZarraga, \{Fernando I\}",

note = "Clin Breast Cancer. 2005 Feb;5(6):447-54. Clinical Trial; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't",

year = "2005",

language = "American English",

volume = "5",

journal = "Clinical Breast Cancer",

}

TY - JOUR

T1 - Weekly docetaxel/carboplatin as primary systemic therapy for HER2-negative locally advanced breast cancer

AU - P Doliny, J Hurley, I Reis, O Silva, C Gomez, P Velez, C Welsh, J Powell,

AU - de Zarraga, Fernando I

AU - deZarraga, Fernando I

N1 - Clin Breast Cancer. 2005 Feb;5(6):447-54. Clinical Trial; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't

PY - 2005

Y1 - 2005

UR - https://www.ncbi.nlm.nih.gov/pubmed/15748465

M3 - Article

VL - 5

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

ER -

Weekly docetaxel/carboplatin as primary systemic therapy for HER2-negative locally advanced breast cancer

Disciplines

Other files and links

Cite this